View Archive »
About The Cover
The cover for issue 102 of Oncotarget features Figure 9, "Apoptotic resistance to Venetoclax in FLT3 mutated primary samples can be reversed when combined with S63845," by Grundy, et al.
|
|
Table of Contents
News
|
| Keeping CDK18 in balance to prevent DNA replication stress in breast cancer |
|
https://doi.org/10.18632/oncotarget.26517
|
| 37610-37611 |
Editorial
|
| Implantable biomaterials to provide local immunotherapy following surgical resection |
|
https://doi.org/10.18632/oncotarget.26487
|
| 37612-37613 |
|
| The Janus face of rosiglitazone |
|
https://doi.org/10.18632/oncotarget.26532
|
| 37614-37615 |
Research Papers
|
| piRNA8041 is downregulated in human glioblastoma and suppresses tumor growth in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.26331
|
| 37616-37626 |
|
| TNFα mediated ceramide generation triggers cisplatin induced apoptosis in B16F10 melanoma in a PKCδ independent manner |
|
https://doi.org/10.18632/oncotarget.26478
|
| 37627-37646 |
|
| A study of meiomitosis and novel pathways of genomic instability in cutaneous Tcell lymphomas CTCL |
|
https://doi.org/10.18632/oncotarget.26479
|
| 37647-37661 |
|
| Preclinical characterization of tyrosine kinase inhibitorbased targeted therapies for neuroendocrine thyroid cancer |
|
https://doi.org/10.18632/oncotarget.26480
|
| 37662-37675 |
|
| A comparison of prostate cancer bone metastases on 18FSodium Fluoride and Prostate Specific Membrane Antigen 18FPSMA PET/CT: Discordant uptake in the same lesion |
|
https://doi.org/10.18632/oncotarget.26481
|
| 37676-37688 |
|
| Pancancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures |
|
https://doi.org/10.18632/oncotarget.26485
|
| 37689-37699 |
|
| Targeting CD74 in multiple myeloma with the novel sitespecific antibodydrug conjugate STRO001 |
|
https://doi.org/10.18632/oncotarget.26491
|
| 37700-37714 |
|
| Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26503
|
| 37715-37720 |
|
| Clinical and prognostic significance of circulating levels of angiopoietin1 and angiopoietin2 in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26507
|
| 37721-37732 |
|
| Divergent roles of lysyl oxidase family members in ornithine decarboxylase and RAStransformed mouse fibroblasts and human melanoma cells |
|
https://doi.org/10.18632/oncotarget.26508
|
| 37733-37752 |
|
| Targeting protein kinase CK2 and CDK4/6 pathways with a multikinase inhibitor ON108110 suppresses prosurvival signaling and growth in mantle cell lymphoma and Tacute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.26514
|
| 37753-37765 |
|
| Neoadjuvant intraarterial chemotherapy using an original fourlumen doubleballoon catheter for locally advanced uterine cervical cancer |
|
https://doi.org/10.18632/oncotarget.26518
|
| 37766-37776 |
|
| Genetic biomarkers predict response to dual BCL2 and MCL1 targeting in acute myeloid leukaemia cells |
|
https://doi.org/10.18632/oncotarget.26540
|
| 37777-37789 |
Reviews
|
| Precision medicine in the treatment stratification of AML patients: challenges and progress |
|
https://doi.org/10.18632/oncotarget.26492
|
| 37790-37797 |
|
| Green tea extract for prevention of prostate cancer progression in patients on active surveillance |
|
https://doi.org/10.18632/oncotarget.26519
|
| 37798-37806 |
Corrections
|
| Correction: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26547
|
| 37807-37807 |
|
| Correction: MMTVNeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment |
|
https://doi.org/10.18632/oncotarget.26548
|
| 37808-37808 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
